MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $84.4 million in its fourth quarter.
On a per-share basis, the Menlo Park, California-based company said it had a loss of 37 cents. Losses, adjusted for non-recurring costs and amortization costs, were 35 cents per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 35 cents per share.
The maker of genetic analysis technology posted revenue of $27.4 million in the period.
For the year, the company reported a loss of $314.2 million, or $1.40 per share. Revenue was reported as $128.3 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PACB at https://www.zacks.com/ap/PACB
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.